Diseases of liporegulation: new perspective on obesity and related disorders

被引:344
作者
Unger, RH
Orci, L
机构
[1] Univ Texas, SW Med Ctr, Gifford Labs, Touchstone Ctr Diabet Res,Dept Internal Med, Dallas, TX 75216 USA
[2] Vet Affairs N Texas Hlth Care Syst, Dallas, TX USA
[3] Univ Geneva, Sch Med, Dept Morphol, Geneva, Switzerland
关键词
D O I
10.1096/fj.00-0590
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Obesity-related diseases now threaten to reach epidemic proportions in the United States, Here we review in a rodent model of genetic obesity, the fa/fa Zucker diabetic fatty (ZDF) rat, the mechanisms involved in the most common complications of diet-induced human obesity, i.e., noninsulin-dependent diabetes mellitus, and myocardial dysfunction. In ZDF rats, hyperphagia leads to hyperinsulinemia, which upregulates transcription factors that stimulate lipogenesis. This causes ectopic deposition of triacylglycerol in nonadipocytes, providing fatty acid (FA) substrate for damaging pathways of nonoxidative metabolism, such as ceramide synthesis, In beta cells and myocardium, the resulting functional impairment and apoptosis cause diabetes and cardiomyopathy, Interventions that lower ectopic lipid accumulation or block nonoxidative metabolism of FA and ceramide formation completely prevent these complications, Given the evidence for a similar etiology for the complications of human obesity, it would be appropriate to develop strategies to avert the predicted epidemic of lipotoxic disorders.
引用
收藏
页码:312 / 321
页数:10
相关论文
共 90 条
  • [1] AILHAUD G, 2000, INT J OBES RELAT M S, pS1
  • [2] OBESITY AND THE HEART
    ALPERT, MA
    HASHIMI, MW
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1993, 306 (02) : 117 - 123
  • [3] Obesity and left ventricular diastolic dysfunction
    Berkalp, B
    Cesur, V
    Corapcioglu, D
    Erol, C
    Baskal, N
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 1995, 52 (01) : 23 - 26
  • [4] Bielawska AE, 1997, AM J PATHOL, V151, P1257
  • [5] Identification of SOCS-3 as a potential mediator of central leptin resistance
    Bjorbaek, C
    Elmquist, JK
    Frantz, JD
    Shoelson, SE
    Flier, JS
    [J]. MOLECULAR CELL, 1998, 1 (04) : 619 - 625
  • [6] Cardiac findings in generalized lipodystrophy
    Bjornstad, PG
    Foerster, A
    Ihlen, H
    [J]. ACTA PAEDIATRICA, 1996, 85 : 39 - 43
  • [7] BROWN MS, 1978, J BIOL CHEM, V253, P1121
  • [8] RECEPTOR-MEDIATED CONTROL OF CHOLESTEROL-METABOLISM
    BROWN, MS
    GOLDSTEIN, JL
    [J]. SCIENCE, 1976, 191 (4223) : 150 - 154
  • [9] Treatment with the oral antidiabetic agent troglitazone improves beta cell responses to glucose in subjects with impaired glucose tolerance
    Cavaghan, MK
    Ehrmann, DA
    Byrne, MM
    Polonsky, KS
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (03) : 530 - 537
  • [10] CHIEN KR, 1983, AM J PATHOL, V112, P68